About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Efficacy of Emerging Nano-medicine Therapies Linked to Shape

by Rajashri on August 7, 2008 at 3:03 PM
Font : A-A+

 Efficacy of Emerging Nano-medicine Therapies Linked to Shape

Tiny particles behave differently within cells depending upon their shapes, sizes, and surface chemistry, according to nanotechnology researchers at the University of North Carolina at Chapel Hill.

Published in the online edition of the journal PNAS, their findings may be helpful in developing effective nanomedicines for cancer.

Advertisement

Dr. Joseph DeSimone, Chancellor's Eminent Professor of Chemistry in UNC's College of Arts and Sciences, has revealed that his research team used a special technique to make particles with specific shapes, sizes, and surface charges for their study.

He said that their purpose was to optimise particle attributes for specific therapeutic objectives.

"This would mean that we could deliver lower dosages of drugs to specific cells and tissues in the body and actually be more effective in treating the cancer," he said.
Advertisement

Having created particles of different dimensions, he added, the group changed one variable at a time, and experimented with different surface chemistries.

Dr. DeSimone says that the different particles were later incubated with human cervical carcinoma epithelial (HeLa) cells, and the group monitored each type to see which ones the cells absorbed most effectively.

He said that the long, rod-shaped particles were found to be internalised by cells about four times faster than lower aspect ratio particles.

Such particles also travelled significantly further into the cell, he added.

Stephanie Gratton, a graduate student in DeSimone's lab, said that the same phenomenon is found in natural organisms.

"If we can design particles that rely on the same mechanisms that nature has perfected for bacteria, we may unlock the key for delivering therapeutics more efficiently and effectively to treat and cure disease," she said.

Liquidia Technologies, a UNC spin-off company, is developing engineered nanoparticles for delivery of nucleic acids and small molecule therapeutics.

The company's chief executive officer, Neal Fowler, said that the new findings could prove of interest to the biopharmaceutical industry.

"We are delighted to contribute to the important work that Professor DeSimone and his students are undertaking in the field of nanomedicine. This work answers key questions about the role of particle shape and size that industry leaders have been asking for some time," Fowler said.

Source: ANI
RAS/L
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
International Day of Persons with Disabilities 2021 - Fighting for Rights in the Post-COVID Era
Effect of Blood Group Type on COVID-19 Risk and Severity
Woman with Rare Spinal Cord Defect from Birth Sues Doctor
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.


Recommended Reading
Tumor Cells can Be Killed With Nanoparticles and Light Combo
University of Virginia medical physicists have come up with a new idea to kill tumour cells with ......
Study Says Nanoparticles may Help Fight Disease
American scientists have developed ultra-miniature bialy-shaped particles called nanobialys that ......
Cancer-Detecting Nanoparticles Developed
A chemist at Brown University claims to have developed the smallest iron oxide nanoparticles to ......

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use